Combining immune checkpoint therapy with photodynamic therapy (PDT) reverses the immunosuppressive cold tumor micro–environment (TME) to a hot TME and stimulates the tumor to respond to the PD–L1 inhibitors [14,15]. This evidence concerns the gene CD274 and neoplasm.